Accretion Nutraveda Ltd
Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products in various dosage forms.[1]
- Market Cap ₹ 122 Cr.
- Current Price ₹ 168
- High / Low ₹ 201 / 150
- Stock P/E 46.6
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 56.7 %
- ROE 81.2 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 89.5%
Cons
- Working capital days have increased from 42.5 days to 111 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Part of BSE SME IPO
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 2.89 | 5.01 | 16.00 | |
| 2.27 | 3.78 | 12.28 | |
| Operating Profit | 0.62 | 1.23 | 3.72 |
| OPM % | 21.45% | 24.55% | 23.25% |
| 0.17 | 0.19 | 0.05 | |
| Interest | 0.19 | 0.24 | 0.35 |
| Depreciation | 0.31 | 0.26 | 0.24 |
| Profit before tax | 0.29 | 0.92 | 3.18 |
| Tax % | 3.45% | 9.78% | 17.92% |
| 0.28 | 0.82 | 2.61 | |
| EPS in Rs | 7.78 | 22.78 | 53.59 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 219% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 218% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 90% |
| Last Year: | 81% |
Balance Sheet
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|
| Equity Capital | 0.36 | 0.36 | 0.49 | 5.32 |
| Reserves | -0.10 | 0.72 | 4.86 | 2.95 |
| 1.97 | 2.17 | 3.86 | 4.43 | |
| 1.83 | 1.39 | 1.65 | 3.65 | |
| Total Liabilities | 4.06 | 4.64 | 10.86 | 16.35 |
| 1.49 | 1.28 | 2.02 | 1.86 | |
| CWIP | 0.00 | 0.10 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| 2.57 | 3.26 | 8.84 | 14.49 | |
| Total Assets | 4.06 | 4.64 | 10.86 | 16.35 |
Cash Flows
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 0.68 | 0.23 | -2.21 | |
| -0.01 | -0.16 | -0.87 | |
| -0.63 | -0.04 | 2.98 | |
| Net Cash Flow | 0.04 | 0.03 | -0.10 |
Ratios
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 101.04 | 18.21 | 74.60 |
| Inventory Days | 279.12 | 303.74 | 158.50 |
| Days Payable | 354.26 | 113.58 | 30.73 |
| Cash Conversion Cycle | 25.89 | 208.37 | 202.36 |
| Working Capital Days | 8.84 | 7.29 | 111.32 |
| ROCE % | 42.34% | 56.66% |
Business Profile[1]
Accretion Nutraveda Limited is a healthcare-focused Ayurveda and Nutraceutical CDMO, manufacturing a wide range of Ayurvedic and nutraceutical products across multiple dosage forms for domestic clients, merchant exporters, and direct export customers.